Correlation of serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension in chronic liver disease

Similar documents
Original article Correlation between serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension

Original Research Article. Shanker Suman 1 *, Divya Jyoti 2, Pramod Kumar Agrawal 1, Bijoy Kumar Bhattacharya 2

Evaluation of Clinical, Biochemical and Ultrasound Parameters in Diagnosis of Oesophageal Varices

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

Detection of Esophageal Varices in Liver Cirrhosis Using Non-invasive Parameters

Original Article PLATELET COUNT TO SPLEEN DIAMETER RATIO AS A PREDICTOR OF ESOPHAGEAL VARICES IN PATIENTS OF LIVER CIRRHOSIS DUE TO HEPATITIS C VIRUS

Esophageal Varices Beta-Blockers or Band Ligation. Cesar Yaghi MD Hotel-Dieu de France University Hospital Universite Saint Joseph

Editorial Process: Submission:07/25/2018 Acceptance:10/19/2018

Corresponding Author: *Dr. G. Bala Bhaskara Reddy, Associate Professor, Pediatrics, FIMS (Fathima Institute of Medical Sciences, Kadapa, A.P.

Correlation between Serum-Ascites Albumin Gradient and Esophageal Varices in Patients with Portal Hypertension

Etiological factor of ascites and its correlation with serum ascites albumin gradient and cholesterol gradient in patients admitted at rural area

BETA-BLOCKERS IN CIRRHOSIS.PRO.

CIRROSI E IPERTENSIONE PORTALE NELLA DONNA

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL

ORIGINAL ARTICLES LIVER, PANCREAS AND BILIARY TRACT

Sandipan Ghose, Md. Azizul Hoque, Md. Khalilur Rahman, Mohd. Harun-or-Rashid

World Health Organization. Western Pacific Region

Title: The Baveno VI criteria for predicting esophageal varices: validation in real life practice

Upper Gastrointestinal Bleeding Score for Differentiating Variceal and Nonvariceal Upper Gastrointestinal Bleeding ABSTRACT

Primary Prophylaxis against Variceal Hemorrhage Pharmacotherapy vs Endoscopic Band Ligation

JMSCR Vol 05 Issue 11 Page November 2017

DISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea

Journal of American Science 2014;10(10)

Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients

CHAPTER 1. Alcoholic Liver Disease

Evidence-Base Management of Esophageal and Gastric Varices

Screening for Portal Hypertension in Cirrhosis

Module 1 Introduction of hepatitis

European. Young Hepatologists Workshop. Organized by : Quantification of fibrosis and cirrhosis outcomes

Is pharmacological therapy the best choice for primary prevention of variceal hemmorhaging in patients with hepatic cirrhosis?

Evaluation of liver and spleen stiffness using a ultrasound guided method: Accuracy of ARFI(R) measurements in liver disease patients

P ortal hypertension commonly accompanies the presence

Variceal bleeding. Mainz,

Detection of Esophageal Varices Using CT and MRI

The Value of Renal Artery Resistive Indices: Association with

Liver Transplantation: The End of the Road in Chronic Hepatitis C Infection

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide

CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed?

Liver Failure. The most severe clinical consequence of liver disease is liver failure:

Serag Esmat 1 and Dalia Omran 2

Ascites Management. Atif Zaman, MD MPH Oregon Health & Science University Professor of Medicine Division of Gastroenterology and Hepatology

GI bleeding in chronic liver disease

Changes in the Clinical Outcomes of Variceal Bleeding in Cirrhotic Patients: A 10-Year Experience in Gangwon Province, South Korea

ACG & AASLD Joint Clinical Guideline: Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis

MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT

The Egyptian Journal of Hospital Medicine (October 2018) Vol. 73 (9), Page

LIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.

Liver failure &portal hypertension

ENCORE-PH Top-line Results

Corresponding Author: Dr. Ali Saqib, Department of Medicine, Madina Teaching Hospital, Faisalabad.

Cirrhosis is different from Fibrosis

Int. J. Pharm. Sci. Rev. Res., 46(1), September - October 2017; Article No. 07, Pages: 37-41

Controversies in Management of Portal Hypertension and Cirrhosis Complications in the Transplant Candidate

Etiology of liver cirrhosis

Original papers Med Ultrason 2013, Vol. 15, no. 2, Ioan Sporea, Iulia Raţiu, Simona Bota, Roxana Şirli, Ana Jurchiş

Gastrointestinal bleeding is one of the most important

Complications of Cirrhosis

Learning Objectives. After attending this presentation, participants will be able to:

following the last documented transfusion; thereafter, evaluate the residual impairment(s).

Hepatitis Panel/Acute Hepatitis Panel

Severity and Mortality Prediction in Chronic Liver Disease using Child PUGH and MELD scales

Comparison between Combination of Band ligation and Propranolol with Propranolol alone in Secondary Prophylaxis of Variceal bleed

The Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust

King Abdul-Aziz University Hospital (KAUH) is a tertiary

Michele Bettinelli RN CCRN Lahey Health and Medical Center

B C Outlines. Child-Pugh scores

Liver Diseases. Yasmine Lashine MD, PhD

Hepatocellular carcinoma in eastern India, a detail analytical report from a tertiary care hospital

Case Report: Refractory variceal bleeding Christophe Hézode, Henri Mondor Hospital, Paris-Est University, Créteil, France

Gamal F. El Naggar (1), Eman A. Alzamarany (2)

Study On Ascitic Fluid Complement3 Level In Cirrhotic Patients With Spontaneous Bacterial Peritonitis And Without Spontaneous Bacterial Peritonitis

Prevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study

ORIGINAL ARTICLES LIVER, PANCREAS, AND BILIARY TRACT

Initial Evaluation for HCV Therapy. Hope McGratty PA-C, MPH

Ammonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis

Pediatric Hepatobiliary, Pancreatic & Splenic US

Pre-operative prediction of difficult laparoscopic cholecystectomy

The Liver for the Nonhepatologist

Hepatitis Panel/Acute Hepatitis Panel

Supplemental Appendix. 1. Protocol Definition of Sustained Virologic Response. A patient has a sustained virologic response if:

th Annual AISF Meeting 44 th th th, 2011 Rome, February 23 rd -26

Cirrhosis Patient Teaching Information

Definition: fibrosis and nodular regeneration resulting from hepatocellular injury

Update in abdominal Surgery in cirrhotic patients

CIRRHOSIS Definition

Diagnostic Procedures. Measurement of Hepatic venous pressure in management of cirrhosis. Clinician s opinion

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

Clinical Endoscopic Parameters of Upper Gastrointestinal Bleeding Hemal Shah, 1 T. P. Manohar 2

Approach to the Patient with Liver Disease

Supplemental Tables. Parasitic Schistosomiasis increase < 1. Genetic Hemochromatosis increase < 1. autoimmune Autoimmune hepatitis (AIH) increase < 1

CASES FOR DISCUSSION. Yohannes B

PORTAL HYPERTENSION. Tianjin Medical University LIU JIAN

Conflict of interest disclosures. Complications of end stage liver disease. None. The many complications of Cirrhosis. Portal Hypertension.

Transfusion strategies in patients with cirrhosis: less is more. 1. Department of Gastroenterology, Hillingdon Hospital, London, UK

Anaesthetic considerations and peri-operative risks in patients with liver disease

Assessment of Liver Function: Implications for HCC Treatment

Index. Note: Page numbers of article titles are in boldface type.

Hepatitis Alert: Management of Patients With HCV Who Have Achieved SVR

Surveillance for Hepatocellular Carcinoma

Carvedilol or Propranolol in the Management of Portal Hypertension?

Transcription:

International Journal of Advances in Medicine Suresh I et al. Int J Adv Med. 2018 Feb;5(1):159-163 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20180077 Correlation of serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension in chronic liver disease Suresh I 1, Shiva Prasad Jagini 2 * 1 Assistant Professor, Department of General Medicine, Kamineni Institute of Medical Sciences, Narketpally, Nalgonda Dist., Telangana, India 2 Assistant Professor, Department of General Medicine, Kamineni Academy of Medical Sciences and Research Centre, LB Nagar, Hyderabad, Telangana, India Received: 23 November 2017 Accepted: 21 December 2017 *Correspondence: Dr. Shiva Prasad Jagini, E-mail: drjaginishiva@gmail.com Copyright: the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: In many studies Serum ascitic albumin gradient (SAAG) was found to be an independent predictor of PHTN and EV especially in alcoholic cirrhosis. Objectives of this study was to study correlation of level of Serum- Ascites Albumin Concentration Gradient (SAAG) and complications of Portal hypertension (PHTN), manifested by Esophageal Varices (EV). Methods: Present study was hospital based cross sectional study. The sample (100) was of patients with ascites. SAAG was measured in all subjects. EV was assessed by endoscopy in all. Data was analyzed using proportions and appropriate statistical tests. Results: High SAAG value was seen in 79% of the patients. EV incidence was 84.5%. child-pugh score and size of the portal vein was found to be associated with EV. The incidence of EV among patients with high SAAG value of 1.1 to 1.44 g/dl was 50%. The size of the EV was found to be significantly associated with SAAG level. Conclusions: Patients having ascites with EV were also having high levels of SAAG. Thus, we conclude that value of SAAG more than or equal to 1.2±0.05 g/dl can be used as a predictor of EV presence among ascites patients. Keywords: Ascites, Cirrhosis of liver, SAAG INTRODUCTION Among the internal organs of the body, liver is the largest. It receives blood supply not only from portal vein but also from hepatic artery. Liver has many functions. These essential Functions become impaired when liver develops cirrhosis. Chronic liver disease (CLD) including cirrhosis is currently twelfth leading cause of death in US, ninth leading cause of death in India. 1,2 Cirrhosis of liver is mainly due to hepatitis C infection and alcoholism of long standing duration. 3 Chronicity of liver disease is determined either by duration of liver disease or by evidence of either severe liver disease or physical stigmata of chronic liver disease. Cirrhosis of liver is usually associated with portal hypertension. The most common complication of portal hypertension is esophageal varices with incidence of 60-80%. 4,5 The death rate due to EV bleeding is 17-57%. These patients are at risk of bleeding or rupture which leads to death. 6,7 The American Association for the Study of Liver Disease single topic symposium 1996 guideline says that all patients with cirrhosis of liver and portal hypertesion should be screened for EV. Baveno III International Journal of Advances in Medicine January-February 2018 Vol 5 Issue 1 Page 159

Consensus Conference on PHTN recommended the same. Some authors suggest to carry out endoscopy at regular intervals. 8,9 Endoscopic screening may take place under two circumstances: at the initial diagnosis of cirrhosis, since EV are an independent predictive factor and an early complication of cirrhosis, and during the follow-up of patients with cirrhosis without EV at risk of bleeding at first examination with or without decompensation. 8 It has been estimated that it is only the large esophageal varices (LEV), which are associated with a substantially increased risk of variceal bleed. The reported incidence of LEV ranges from 9% to 49%. In a recent review, Boyer, using a prevalence of LEV of 20%, estimated that a 100 screening endoscopic examination need to be performed to prevent 1 to 2 cases of variceal bleeding. 4 The SAAG has been defined as the serum albumin concentration minus the ascitic fluid albumin concentration. The SAAG is superior to the exudate transudate concept to classify ascites, being an exact PHTN marker. 6 There are scant studies in the literature to evaluate SAAG and EV in the patients with non-alcoholic cirrhosis. When the value of SAAG was more than 2, strong correlation existed even in Non-alcoholic cirrhosis. Hence present study was carried out to identify noninvasive parameters for prediction of esophageal varices (EV) in newly diagnosed patients with cirrhosis. METHODS Type of Study: Cross sectional study. Sample size: 100 patients. Place of study: Department of General Medicine, Basaveshwar Teaching and General Hospital, Gulbarga attached to Mahadevappa Rampure Medical College. Duration of study: January 2011 to May 2012. Inclusion Criteria All newly diagnosed cases of chronic liver disease with Ascites and confirmed by physical examination, biochemical parameters, and Ultra sound Abdomen. Exclusion Criteria Patients with pregnancy, bleeding from existing portal hypertension, having AIDS, currently on beta blockers were excluded from the present study. All patients in this study underwent a full clinical evaluation i.e., clinical history and physical examination and findings were recorded with particular attention to present or previous history of yellowish discoloration of sclera, abdominal swelling, swelling of both lower limbs, hematemesis, melena, bleeding per rectum, bleeding tendencies, alcoholism, blood transfusion, intake of hepatotoxic drugs, exposure to Sexually transmitted diseases, IV drug abuse, jaundice, anemia, edema, stigmata of chronic liver disease, dilated abdominal veins, ascites, splenomegaly and encephalopathy. Necessary investigations and endoscopy was carried out among the patients. Ultrasonographic features of cirrhosis include coarse echogenic echo texture, nodular surface and regenerating nodules surrounded by fibrous septae. The nodules are seen as iso to hypo-echoic lesions with echogenic borders corresponding to fibrous septa. The caudate lobe to right lobe of liver ratio of > 0.65 is highly specific to cirrhosis. Ultrasonographic features of portal hypertension is based on demonstration of underlying liver disease, splenomegaly, ascites, dilated portal vein (> 13 mm diameter) and presence of collaterals. Portal vein velocity is reduced in portal hypertension. Blood sample was collected as per the guidelines. 10 Serum albumin as well as albumin in the ascitic fluid was determined with standard technique. 11 Endoscopy was performed with standard guidelines. 12 Grading I II III TABLE 1: EV was graded as follows. 13 Statistical analysis Esophageal varices Small and straight Tortuous and occupying<1/3 rd of the lumen Large and occupying <1/3 rd of the lumen Data were collected in a predetermined proforma and results were analyzed using Software Statistical package student science (SPSS) version 14.0. Continuous variables were analyzed using student unpaired t-test and categorical variables by Chi square test (χ2). Pearson Correlation was used to find correlation between two variables. Receiver operating characteristic curve was used to find the SAAG value with best sensitivity and specificity for predicting EV. A p value of < 0.05 was considered statistically significant, p value of < 0.01 was considered highly significant and p value of < 0.001 was considered very highly significant. RESULTS Table 2: Distribution of cases based on etiology. Etiology Number of Cases Alcoholic 75 (75%) HBV 10 (10%) HCV 14 (14%) Wilson disease 1 (1%) 100 In this study Maximum number of patients with cirrhosis were due to alcohol (75%), followed by HCV (14 %), HBV (10%), and 1 case of Wilsons disease. International Journal of Advances in Medicine January-February 2018 Vol 5 Issue 1 Page 160

Table 3: Distribution of cases based on grade of esophageal varices. Frequency 0 33 (33%) I 18 (18%) II 19 (19%) III 30 (30%) 100 Among 100 patients in this study 67 patients had esophageal varices. 30 % patients had grade III esophageal varices, 19% had grade II and 18 % had grade I esophageal varices respectively. Table 4: Relation between hepatic encephalopathy and varices. Hepatic encephalopathy Yes No 0 0 33 33 I 1 17 18 II 4 15 19 III 5 25 30 10 90 100 χ2= 6.70; P=0.15 NS No significant relation between presence of hepatic encephalopathy and grade of varices was found. Table 5: Association between EV and SAAG values. Esophageal High SAAG Low SAAG varices (>1.1) (<1.1) Presence 67 3 70 Absence 12 18 30 79 21 100 χ2= 39.29; P < 0.001 S 84.5 % of the study population had varices when SAAG value was more than 1.1 g/dl (P < 0.001) and there is very highly significant relation found between high SAAG and presence of esophageal varices. Table 6: Relationship between child Pugh score and varices. CP grade A B C 0 3 21 9 33 I 5 12 1 18 II 4 8 7 19 III 5 16 9 30 17 57 26 100 χ2= 31.5 P=0.01 S Patients were grouped according to Child Pugh Classification of Cirrhosis. The relationship between Child Pugh Grade and the grade of varices was studied and significant correlation noted (P = 0.01). Table 7: Relationship between portal vein size and presence of Varices. Parameter Varices Number of patient Portal vein size Present 67 (> 13 mm) Absent 33 t=2.03, P<0.05 S Significance was noted between portal vein size (mm) and presence of varices in the study group. Table 8: Distribution based on SAAG values. SAAG Frequency < 1.1 21 1.1 1.44 30 1.45-1.99 20 > 2 29 100 In this study 21% of study population had SAAG < 1.1, and 79 % had SAAG > 1.1, among high SAAG 30 (37.6%) had SAAG value between 1.1-1.44, 20 (25.3%) had SAAG value between 1.45 1.99 and 29 (36.3) had SAAG value >2. Table 9: Relationship between SAAG and grade of varices. SAAG I II III <1.1 3 0 0 3 1.1 1.44 4 4 7 15 1.45 1.99 5 5 10 20 >2 6 10 13 29 18 19 30 67 Correlation Co-efficient (r) = 0.607, p < 0.01 S When the Value of SAAG was < 1.1 g/dl it was noted that Grade II and III varices were absent. When the SAAG values increased more than 1.1 g/dl, there was considerable increase in grading of varices. There was highly significant association found between SAAG and grade of varices. Table 10: Role of SAAG in predicting varices in cirrhotic patients with ascites. Esophageal varices Present Absent SAAG <1.1 3 18 21 SAAG >1.1 67 12 79 70 30 100 It has been observed from above table that when SAAG value was more than 1.1 then the possibility of having International Journal of Advances in Medicine January-February 2018 Vol 5 Issue 1 Page 161

esophageal varices was more than with value of less than 1.1. Table 11: Diagnostic accuracy of SAAG in predicting presence of varices. Value in % 95 % CI Sensitivity 81 62 94 Specificity 100 63 100 False positive 0 0 33 False negative 19 6 38 Positive predictive value 100 85 100 Negative predictive value 64 35 87 The sensitivity of SAAG >1.1 in predicting the presence of varices is 81% and its specificity and positive predictive value is 100%. DISCUSSION Our study sample consists of hundred patients of whom eighty were male and twenty were females. The mean age was 44.5 (SD = 11.8). In present study Maximum number of patients with cirrhosis were due to alcohol (75 %), followed by HCV (14%), HBV (10%), and 1 case of Wilsons disease and these patients presented with symptoms of abdominal distension in all patients, 73% presented with yellowish discoloration of sclera, 54% presented with swelling of lower limbs, 29% presented with hematemesis, 28 % had malena and 10% presented with altered sensorium All patients in the study group had ascites; other frequent signs elicited were visible abdominal veins (78%), Decreased axillary and pubic hairs (70%), splenomegaly (67%), spider nevi (35%), gynecomastia (35%), palmar erythema (10%), and flapping tremors (10%). Keiser Fleischer s ring was observed only in 1 patient. We studied the frequency of distribution based on grading of varices and found that Grade I in 18%, grade II in 19%, grade III in 30% and 33% of study sample did not have EV. 10 patients in the study population presented with hepatic encephalopathy and present study did not find any association with varices. Patients were grouped according to Child Pugh Classification of Cirrhosis. The relationship between Child Pugh Grade and the grade of varices was studied and significant correlation noted (P=0.001) Thus as patients progress to decompensate liver disease (CP Grade B & C) it is noted that the presence of varices increases. This is finding is consistent with study by Madhotra et al and Zaman et al. 14,15 Significance was noted between portal vein size (cm) and presence of varices. Similar results were obtained in study by D Amico et al. 16 We grouped patients based on range of SAAG values. Of the study sample SAAG was less than 1.1 in 21% of the patients and more than 1.1 in 79 %. 84.5 % of the study population had varices when SAAG value was more than 1.1. 14.28% of patients in whom varices were present had SAAG values less than 1.1. The two groups showed statistically significant difference (P=0.001) based on presence and absence of varices. This is consistent with studies by Torres et al, Gurubacharya et al, Kajani et al, Dittrich et al. 17-20 We also assessed the correlation between grade of varices and SAAG values. When the Value of SAAG was < 1.1 it was noted that Grade II and III varices were absent. When the SAAG values increased more than 1.1, there was considerable increase in grading of varices. In our study there was moderate correlation (r= 0.607) between SAAG and grade of varices. This finding is similar to the study by Torres et al, Gurubacharya et al and Demyrel et al. 17,18,21 We found that when the cut off value of SAAG was taken as 1.20±0.05 gm/dl it was noted that the test achieved 100 % specificity and sensitivity ranging from 77.8 to 81.5%. But Torres et al stated that the SAAG value must be considered > 1.435±0.015 gm/dl for predicting EV. The sensitivity of SAAG > 1.1 g/dl in predicting the presence of varices in the subgroup of patients with ascites was 81 % (95% CI; 62-94) and its positive predictive value is 100 % (95% CI = 85-100) Thus, use of SAAG may help to identify patients with a probability of esophageal varices that may not need endoscopy. This may help reduce costs and discomfort for these patients and the burden on endoscopy units. CONCLUSION In conclusion, we state that high SAAG values are seen among patients of EV with liver cirrhosis. SAAG degree is directly proportional to the size and presence of EV among these patients. We give value of SAAG as > 1.2± 0.05 g/dl which will help in predicting whether the portal hypertension is present or not. Funding: No funding sources Conflict of interest: None declared Ethical approval: The study was approved by the institutional ethics committee REFERENCES 1. Minino AM, Smith BL. Deaths: preliminary data for 2000. Natl Vital Stat Rep. 2001;49:1-40. 2. World Life Expectancy. Available from: worldlifeexpectancy.com/world-rankings-totaldeaths. International Journal of Advances in Medicine January-February 2018 Vol 5 Issue 1 Page 162

3. Diehl AM. Alcoholic liver disease. Med Clin North AM. 1989;73:815-30. 4. D Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatol. 1995;22:332-54. 5. D Amico G, Luca A. Natural history. Clinicalhaemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol. 1997;11:243-56. 6. D amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatol. 2003;38:599-612. 7. Graham D, Smith J. The course of patients after variceal hemorrhage. Gastroenterol. 1981;80:800-6. 8. De Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000;33:846-52. 9. De Franchis R. Evaluation and follow-up of patients with cirrhosis and oesophageal varices. J Hepatol 2003;38:361-3. 10. Runyon BA. Ascites and spontaneous bacterial peritonitis. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal diseases: pathophysiology diagnosis, management, Vol II. Philadelphia: W.B. Saunders Company. 1993;1977-2003. 11. Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient in the differential diagnosis of ascites is superior to the exudate-transudate concept. Ann Intern Med. 1992;117:215-20. 12. Sherlock S. Ascites. In: Sherlock S, Dooley J, eds. Diseases of the liver and biliary system, ninth edition. Oxford: Blackwell Scientific Publications. 1993:114-31. 13. Graham D, Smith J. The course of patients after variceal hemorrhage. Gastroenterol. 1981;80:800. 14. Madhotra R, Mulcahy HE, Willner I. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2002;34:81-5. 15. Zaman A, Becker T, Lopidus J. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Int Med. 2001;161:2564-70. 16. D Amico G, Morabito A. Non invasive markers of esophageal varices: Another round, not the last. Hepatol. 2004;39(1):30-4. 17. Torres E, Calme F, Herrera B. Echographic parameters in the evaluation of the degree of portal hypertension. Rev Gastroenterol. 1996;16(2):125-32. 18. Gurubacharya DL, Mathura KC, Karki DB. Correlation between serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension. Kathmandu University Medic J. 2005;3(12):327-33. 19. Kajani MA, Yoo YK, Alexandr JA. Serum-ascites albumin gradients in non-alcoholic liver disease. Digestive Disease Science. 1990;35(1):33-7. 20. Dittrich S, Yordi LM, de Mattos AA. The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites. Hepatogastroenterol. 2001;48(37):166-8. 21. Demyrel U, Karincaoglu U, Harpttuoqlu M et al. Two findings of portal hypertension: Evaluation of correlation between serum-ascites albumin concentration gradient and esophageal varices in non alcoholic cirrhosis. Turkish J Gastroenterol. 2003;14(4):219-22. Cite this article as: Suresh I, Jagini SP. Correlation of serum-ascites albumin concentration gradient and endoscopic parameters of portal hypertension in chronic liver disease. Int J Adv Med 2018;5:159-63. International Journal of Advances in Medicine January-February 2018 Vol 5 Issue 1 Page 163